alagebrium has been researched along with Impotence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ender Caylan, A; Gurbuz, N; Gurkan, R; Surmen Usta, S; Usta, MF | 1 |
| Gao, Z; Guan, R; Li, G; Li, H; Tian, W; Uwais, Z; Wang, L; Xin, Z | 1 |
2 other study(ies) available for alagebrium and Impotence
| Article | Year |
|---|---|
The therapeutic effect of ALT-711 on erectile function in rats treated with high-level AGEs (advanced glycation end products) containing diet.
Topics: Animals; Diabetes Mellitus, Experimental; Diet; Erectile Dysfunction; Glycation End Products, Advanced; Male; Nitric Oxide Synthase Type III; Penile Erection; Penis; Rats; Rats, Sprague-Dawley; Thiazoles | 2022 |
AGE-breaker ALT-711 plus insulin could restore erectile function in streptozocin-induced type 1 diabetic rats.
Topics: Animals; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Erectile Dysfunction; Hypoglycemic Agents; Insulin; Male; Malondialdehyde; Nitric Oxide Synthase Type I; Oxidative Stress; Penile Erection; Penis; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles | 2014 |